Previous close | 119.47 |
Open | 119.47 |
Bid | 119.94 x 1800 |
Ask | 120.02 x 800 |
Day's range | 118.61 - 121.33 |
52-week range | 89.04 - 125.02 |
Volume | |
Avg. volume | 689,409 |
Market cap | 11.79B |
Beta (5Y monthly) | 0.41 |
PE ratio (TTM) | 63.16 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 29 Dec 1995 |
1y target est | N/A |
Neurocrine Biosciences Inc (NASDAQ:NBIX), a prominent player in the biopharmaceutical industry, has recently witnessed a significant insider sell event.
Neurocrine Biosciences Inc (NASDAQ:NBIX), a prominent player in the biopharmaceutical industry, has recently witnessed a significant insider sell by its Chief Legal Officer, Darin Lippoldt.
In this piece, we will take a look at the 12 best low beta stocks to buy. If you want to skip our introduction to the latest stock market news and the beta, then take a look at the 5 Best Low Beta Stocks To Buy. If there’s one thing that can be said with […]